TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 5 | 1 | 6 | 18 | 57 | 144 | 74 | 50 |
| S | %wins | 40 | 20 | 20 | 40 | 40 | 20 | 30 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/4/12 17:11 | 5/2/12 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Aviezer David | L3 | DO | P,CEO | S.d | -3,209 | 7.13 | 11 | -450 | -100 | 0 | I | 0 | 3 | 9 | 12 | 13 | 8 | -6 | -3 | 1 | 0 | -11 | -17 | -27 | -22 |
10/21/09 20:02 | 10/19/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Aviezer David | L3 | DO | CEO,P | S.dm | -2,302 | 9.43 | 6 | -244 | -100 | 0 | I | -74 | 363 | 257 | 54 | 22 | 12 | 1 | -2 | -4 | 2 | 11 | -23 | -26 | 6 |
5/12/09 18:38 | 5/8/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Aviezer David | L3 | DO | P,CEO | S.dm | -341 | 3.41 | 0 | -100 | -100 | 0 | I | -89 | 21 | 133 | 25 | 48 | 31 | 15 | 10 | 1 | 9 | 10 | 79 | 245 | 94 |
5/6/09 19:23 | 5/4/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Aviezer David | L3 | DO | P,CEO | S.dm | -227 | 3.03 | 0 | -75 | -100 | 0 | I | -88 | 12 | 79 | 22 | 33 | 27 | 15 | 4 | 7 | 14 | 27 | 125 | 242 | 121 |
4/20/09 19:37 | 4/16/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Aviezer David | L3 | DO | P,CEO | S.dm | -126 | 2.52 | 0 | -50 | -100 | 0 | I | -92 | -13 | 54 | 31 | -2 | 4 | 13 | 9 | 0 | 4 | 52 | 119 | 287 | 173 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |